Acyclovir/Hydrocortisone

阿昔洛韦/氢化可的松

Report date: 2023/04/24 20:00:24
NME

Base Information

Drug NameAcyclovir/Hydrocortisone
Drug Alias Nameaciclovir + hydrocortisone
ClassificationSmall molecules > SteroidsSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA-directed DNA polymerase inhibitorsGlucocorticoid receptor agonists
TargetsDNA-directed DNA polymeraseGlucocorticoid receptor
Therapy Area/IndicationsHerpes Labialis
Global Approved IndicationsHerpes Labialis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2009/07/31
Country/TerritoryUnited StatesSweden
CombinationsYes AcyclovirHydrocortisone
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Consumer Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Consumer HealthcareBausch & Lomb (Singapore) Pvi Ltd
Inactive CompaniesN/A
Active IndicationsHerpes Labialis
Inactive IndicationsN/A

Other Information

ATC CodeD06BB53
Related LinksN/A